Global Pruritus Ani Medicine Market Growth 2026-2032
The global Pruritus Ani Medicine market size is predicted to grow from US$ 947 million in 2025 to US$ 1323 million in 2032; it is expected to grow at a CAGR of 5.0% from 2026 to 2032.
United States market for Pruritus Ani Medicine is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Pruritus Ani Medicine is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Pruritus Ani Medicine is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Pruritus Ani Medicine players cover AbbVie, Inc. (Allergan plc), Albireo Pharma, Inc., Astellas Pharma Inc., Cipla Limited, Eli Lilly and Company, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the ?Pruritus Ani Medicine Industry Forecast? looks at past sales and reviews total world Pruritus Ani Medicine sales in 2025, providing a comprehensive analysis by region and market sector of projected Pruritus Ani Medicine sales for 2026 through 2032. With Pruritus Ani Medicine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pruritus Ani Medicine industry.
This Insight Report provides a comprehensive analysis of the global Pruritus Ani Medicine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pruritus Ani Medicine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Pruritus Ani Medicine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pruritus Ani Medicine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pruritus Ani Medicine.
This report presents a comprehensive overview, market shares, and growth opportunities of Pruritus Ani Medicine market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
United States market for Pruritus Ani Medicine is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Pruritus Ani Medicine is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Pruritus Ani Medicine is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Pruritus Ani Medicine players cover AbbVie, Inc. (Allergan plc), Albireo Pharma, Inc., Astellas Pharma Inc., Cipla Limited, Eli Lilly and Company, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the ?Pruritus Ani Medicine Industry Forecast? looks at past sales and reviews total world Pruritus Ani Medicine sales in 2025, providing a comprehensive analysis by region and market sector of projected Pruritus Ani Medicine sales for 2026 through 2032. With Pruritus Ani Medicine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pruritus Ani Medicine industry.
This Insight Report provides a comprehensive analysis of the global Pruritus Ani Medicine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pruritus Ani Medicine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Pruritus Ani Medicine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pruritus Ani Medicine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pruritus Ani Medicine.
This report presents a comprehensive overview, market shares, and growth opportunities of Pruritus Ani Medicine market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- External Medication
- Oral Medication
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- AbbVie, Inc. (Allergan plc)
- Albireo Pharma, Inc.
- Astellas Pharma Inc.
- Cipla Limited
- Eli Lilly and Company
- GSK plc
- Merck & Co., Inc.
- Pfizer, Inc.
- Teva Pharmaceutical Industries Ltd.
- Viatris Inc. (Mylan N.V.)
- What is the 10-year outlook for the global Pruritus Ani Medicine market?
- What factors are driving Pruritus Ani Medicine market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do Pruritus Ani Medicine market opportunities vary by end market size?
- How does Pruritus Ani Medicine break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Pruritus Ani Medicine Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Pruritus Ani Medicine by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Pruritus Ani Medicine by Country/Region, 2021, 2025 & 2032
2.2 Pruritus Ani Medicine Segment by Type
2.2.1 External Medication
2.2.2 Oral Medication
2.2.3 Pruritus Ani Medicine Sales by Type
2.2.3.1 Global Pruritus Ani Medicine Sales Market Share by Type (2021-2026)
2.2.3.2 Global Pruritus Ani Medicine Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Pruritus Ani Medicine Sale Price by Type (2021-2026)
2.3 Pruritus Ani Medicine Segment by Application
2.3.1 Hospital Pharmacies
2.3.2 Retail Pharmacies
2.3.3 Online Pharmacies
2.3.4 Pruritus Ani Medicine Sales by Application
2.3.4.1 Global Pruritus Ani Medicine Sale Market Share by Application (2021-2026)
2.3.4.2 Global Pruritus Ani Medicine Revenue and Market Share by Application (2021-2026)
2.3.4.3 Global Pruritus Ani Medicine Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Pruritus Ani Medicine Breakdown Data by Company
3.1.1 Global Pruritus Ani Medicine Annual Sales by Company (2021-2026)
3.1.2 Global Pruritus Ani Medicine Sales Market Share by Company (2021-2026)
3.2 Global Pruritus Ani Medicine Annual Revenue by Company (2021-2026)
3.2.1 Global Pruritus Ani Medicine Revenue by Company (2021-2026)
3.2.2 Global Pruritus Ani Medicine Revenue Market Share by Company (2021-2026)
3.3 Global Pruritus Ani Medicine Sale Price by Company
3.4 Key Manufacturers Pruritus Ani Medicine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Pruritus Ani Medicine Product Location Distribution
3.4.2 Players Pruritus Ani Medicine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR PRURITUS ANI MEDICINE BY GEOGRAPHIC REGION
4.1 World Historic Pruritus Ani Medicine Market Size by Geographic Region (2021-2026)
4.1.1 Global Pruritus Ani Medicine Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Pruritus Ani Medicine Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Pruritus Ani Medicine Market Size by Country/Region (2021-2026)
4.2.1 Global Pruritus Ani Medicine Annual Sales by Country/Region (2021-2026)
4.2.2 Global Pruritus Ani Medicine Annual Revenue by Country/Region (2021-2026)
4.3 Americas Pruritus Ani Medicine Sales Growth
4.4 APAC Pruritus Ani Medicine Sales Growth
4.5 Europe Pruritus Ani Medicine Sales Growth
4.6 Middle East & Africa Pruritus Ani Medicine Sales Growth
5 AMERICAS
5.1 Americas Pruritus Ani Medicine Sales by Country
5.1.1 Americas Pruritus Ani Medicine Sales by Country (2021-2026)
5.1.2 Americas Pruritus Ani Medicine Revenue by Country (2021-2026)
5.2 Americas Pruritus Ani Medicine Sales by Type (2021-2026)
5.3 Americas Pruritus Ani Medicine Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pruritus Ani Medicine Sales by Region
6.1.1 APAC Pruritus Ani Medicine Sales by Region (2021-2026)
6.1.2 APAC Pruritus Ani Medicine Revenue by Region (2021-2026)
6.2 APAC Pruritus Ani Medicine Sales by Type (2021-2026)
6.3 APAC Pruritus Ani Medicine Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Pruritus Ani Medicine by Country
7.1.1 Europe Pruritus Ani Medicine Sales by Country (2021-2026)
7.1.2 Europe Pruritus Ani Medicine Revenue by Country (2021-2026)
7.2 Europe Pruritus Ani Medicine Sales by Type (2021-2026)
7.3 Europe Pruritus Ani Medicine Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Pruritus Ani Medicine by Country
8.1.1 Middle East & Africa Pruritus Ani Medicine Sales by Country (2021-2026)
8.1.2 Middle East & Africa Pruritus Ani Medicine Revenue by Country (2021-2026)
8.2 Middle East & Africa Pruritus Ani Medicine Sales by Type (2021-2026)
8.3 Middle East & Africa Pruritus Ani Medicine Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Pruritus Ani Medicine
10.3 Manufacturing Process Analysis of Pruritus Ani Medicine
10.4 Industry Chain Structure of Pruritus Ani Medicine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Pruritus Ani Medicine Distributors
11.3 Pruritus Ani Medicine Customer
12 WORLD FORECAST REVIEW FOR PRURITUS ANI MEDICINE BY GEOGRAPHIC REGION
12.1 Global Pruritus Ani Medicine Market Size Forecast by Region
12.1.1 Global Pruritus Ani Medicine Forecast by Region (2027-2032)
12.1.2 Global Pruritus Ani Medicine Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Pruritus Ani Medicine Forecast by Type (2027-2032)
12.7 Global Pruritus Ani Medicine Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 AbbVie, Inc. (Allergan plc)
13.1.1 AbbVie, Inc. (Allergan plc) Company Information
13.1.2 AbbVie, Inc. (Allergan plc) Pruritus Ani Medicine Product Portfolios and Specifications
13.1.3 AbbVie, Inc. (Allergan plc) Pruritus Ani Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 AbbVie, Inc. (Allergan plc) Main Business Overview
13.1.5 AbbVie, Inc. (Allergan plc) Latest Developments
13.2 Albireo Pharma, Inc.
13.2.1 Albireo Pharma, Inc. Company Information
13.2.2 Albireo Pharma, Inc. Pruritus Ani Medicine Product Portfolios and Specifications
13.2.3 Albireo Pharma, Inc. Pruritus Ani Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Albireo Pharma, Inc. Main Business Overview
13.2.5 Albireo Pharma, Inc. Latest Developments
13.3 Astellas Pharma Inc.
13.3.1 Astellas Pharma Inc. Company Information
13.3.2 Astellas Pharma Inc. Pruritus Ani Medicine Product Portfolios and Specifications
13.3.3 Astellas Pharma Inc. Pruritus Ani Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Astellas Pharma Inc. Main Business Overview
13.3.5 Astellas Pharma Inc. Latest Developments
13.4 Cipla Limited
13.4.1 Cipla Limited Company Information
13.4.2 Cipla Limited Pruritus Ani Medicine Product Portfolios and Specifications
13.4.3 Cipla Limited Pruritus Ani Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Cipla Limited Main Business Overview
13.4.5 Cipla Limited Latest Developments
13.5 Eli Lilly and Company
13.5.1 Eli Lilly and Company Company Information
13.5.2 Eli Lilly and Company Pruritus Ani Medicine Product Portfolios and Specifications
13.5.3 Eli Lilly and Company Pruritus Ani Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Eli Lilly and Company Main Business Overview
13.5.5 Eli Lilly and Company Latest Developments
13.6 GSK plc
13.6.1 GSK plc Company Information
13.6.2 GSK plc Pruritus Ani Medicine Product Portfolios and Specifications
13.6.3 GSK plc Pruritus Ani Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 GSK plc Main Business Overview
13.6.5 GSK plc Latest Developments
13.7 Merck & Co., Inc.
13.7.1 Merck & Co., Inc. Company Information
13.7.2 Merck & Co., Inc. Pruritus Ani Medicine Product Portfolios and Specifications
13.7.3 Merck & Co., Inc. Pruritus Ani Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Merck & Co., Inc. Main Business Overview
13.7.5 Merck & Co., Inc. Latest Developments
13.8 Pfizer, Inc.
13.8.1 Pfizer, Inc. Company Information
13.8.2 Pfizer, Inc. Pruritus Ani Medicine Product Portfolios and Specifications
13.8.3 Pfizer, Inc. Pruritus Ani Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Pfizer, Inc. Main Business Overview
13.8.5 Pfizer, Inc. Latest Developments
13.9 Teva Pharmaceutical Industries Ltd.
13.9.1 Teva Pharmaceutical Industries Ltd. Company Information
13.9.2 Teva Pharmaceutical Industries Ltd. Pruritus Ani Medicine Product Portfolios and Specifications
13.9.3 Teva Pharmaceutical Industries Ltd. Pruritus Ani Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Teva Pharmaceutical Industries Ltd. Main Business Overview
13.9.5 Teva Pharmaceutical Industries Ltd. Latest Developments
13.10 Viatris Inc. (Mylan N.V.)
13.10.1 Viatris Inc. (Mylan N.V.) Company Information
13.10.2 Viatris Inc. (Mylan N.V.) Pruritus Ani Medicine Product Portfolios and Specifications
13.10.3 Viatris Inc. (Mylan N.V.) Pruritus Ani Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Viatris Inc. (Mylan N.V.) Main Business Overview
13.10.5 Viatris Inc. (Mylan N.V.) Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Pruritus Ani Medicine Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Pruritus Ani Medicine by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Pruritus Ani Medicine by Country/Region, 2021, 2025 & 2032
2.2 Pruritus Ani Medicine Segment by Type
2.2.1 External Medication
2.2.2 Oral Medication
2.2.3 Pruritus Ani Medicine Sales by Type
2.2.3.1 Global Pruritus Ani Medicine Sales Market Share by Type (2021-2026)
2.2.3.2 Global Pruritus Ani Medicine Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Pruritus Ani Medicine Sale Price by Type (2021-2026)
2.3 Pruritus Ani Medicine Segment by Application
2.3.1 Hospital Pharmacies
2.3.2 Retail Pharmacies
2.3.3 Online Pharmacies
2.3.4 Pruritus Ani Medicine Sales by Application
2.3.4.1 Global Pruritus Ani Medicine Sale Market Share by Application (2021-2026)
2.3.4.2 Global Pruritus Ani Medicine Revenue and Market Share by Application (2021-2026)
2.3.4.3 Global Pruritus Ani Medicine Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Pruritus Ani Medicine Breakdown Data by Company
3.1.1 Global Pruritus Ani Medicine Annual Sales by Company (2021-2026)
3.1.2 Global Pruritus Ani Medicine Sales Market Share by Company (2021-2026)
3.2 Global Pruritus Ani Medicine Annual Revenue by Company (2021-2026)
3.2.1 Global Pruritus Ani Medicine Revenue by Company (2021-2026)
3.2.2 Global Pruritus Ani Medicine Revenue Market Share by Company (2021-2026)
3.3 Global Pruritus Ani Medicine Sale Price by Company
3.4 Key Manufacturers Pruritus Ani Medicine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Pruritus Ani Medicine Product Location Distribution
3.4.2 Players Pruritus Ani Medicine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR PRURITUS ANI MEDICINE BY GEOGRAPHIC REGION
4.1 World Historic Pruritus Ani Medicine Market Size by Geographic Region (2021-2026)
4.1.1 Global Pruritus Ani Medicine Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Pruritus Ani Medicine Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Pruritus Ani Medicine Market Size by Country/Region (2021-2026)
4.2.1 Global Pruritus Ani Medicine Annual Sales by Country/Region (2021-2026)
4.2.2 Global Pruritus Ani Medicine Annual Revenue by Country/Region (2021-2026)
4.3 Americas Pruritus Ani Medicine Sales Growth
4.4 APAC Pruritus Ani Medicine Sales Growth
4.5 Europe Pruritus Ani Medicine Sales Growth
4.6 Middle East & Africa Pruritus Ani Medicine Sales Growth
5 AMERICAS
5.1 Americas Pruritus Ani Medicine Sales by Country
5.1.1 Americas Pruritus Ani Medicine Sales by Country (2021-2026)
5.1.2 Americas Pruritus Ani Medicine Revenue by Country (2021-2026)
5.2 Americas Pruritus Ani Medicine Sales by Type (2021-2026)
5.3 Americas Pruritus Ani Medicine Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pruritus Ani Medicine Sales by Region
6.1.1 APAC Pruritus Ani Medicine Sales by Region (2021-2026)
6.1.2 APAC Pruritus Ani Medicine Revenue by Region (2021-2026)
6.2 APAC Pruritus Ani Medicine Sales by Type (2021-2026)
6.3 APAC Pruritus Ani Medicine Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Pruritus Ani Medicine by Country
7.1.1 Europe Pruritus Ani Medicine Sales by Country (2021-2026)
7.1.2 Europe Pruritus Ani Medicine Revenue by Country (2021-2026)
7.2 Europe Pruritus Ani Medicine Sales by Type (2021-2026)
7.3 Europe Pruritus Ani Medicine Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Pruritus Ani Medicine by Country
8.1.1 Middle East & Africa Pruritus Ani Medicine Sales by Country (2021-2026)
8.1.2 Middle East & Africa Pruritus Ani Medicine Revenue by Country (2021-2026)
8.2 Middle East & Africa Pruritus Ani Medicine Sales by Type (2021-2026)
8.3 Middle East & Africa Pruritus Ani Medicine Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Pruritus Ani Medicine
10.3 Manufacturing Process Analysis of Pruritus Ani Medicine
10.4 Industry Chain Structure of Pruritus Ani Medicine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Pruritus Ani Medicine Distributors
11.3 Pruritus Ani Medicine Customer
12 WORLD FORECAST REVIEW FOR PRURITUS ANI MEDICINE BY GEOGRAPHIC REGION
12.1 Global Pruritus Ani Medicine Market Size Forecast by Region
12.1.1 Global Pruritus Ani Medicine Forecast by Region (2027-2032)
12.1.2 Global Pruritus Ani Medicine Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Pruritus Ani Medicine Forecast by Type (2027-2032)
12.7 Global Pruritus Ani Medicine Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 AbbVie, Inc. (Allergan plc)
13.1.1 AbbVie, Inc. (Allergan plc) Company Information
13.1.2 AbbVie, Inc. (Allergan plc) Pruritus Ani Medicine Product Portfolios and Specifications
13.1.3 AbbVie, Inc. (Allergan plc) Pruritus Ani Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 AbbVie, Inc. (Allergan plc) Main Business Overview
13.1.5 AbbVie, Inc. (Allergan plc) Latest Developments
13.2 Albireo Pharma, Inc.
13.2.1 Albireo Pharma, Inc. Company Information
13.2.2 Albireo Pharma, Inc. Pruritus Ani Medicine Product Portfolios and Specifications
13.2.3 Albireo Pharma, Inc. Pruritus Ani Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Albireo Pharma, Inc. Main Business Overview
13.2.5 Albireo Pharma, Inc. Latest Developments
13.3 Astellas Pharma Inc.
13.3.1 Astellas Pharma Inc. Company Information
13.3.2 Astellas Pharma Inc. Pruritus Ani Medicine Product Portfolios and Specifications
13.3.3 Astellas Pharma Inc. Pruritus Ani Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Astellas Pharma Inc. Main Business Overview
13.3.5 Astellas Pharma Inc. Latest Developments
13.4 Cipla Limited
13.4.1 Cipla Limited Company Information
13.4.2 Cipla Limited Pruritus Ani Medicine Product Portfolios and Specifications
13.4.3 Cipla Limited Pruritus Ani Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Cipla Limited Main Business Overview
13.4.5 Cipla Limited Latest Developments
13.5 Eli Lilly and Company
13.5.1 Eli Lilly and Company Company Information
13.5.2 Eli Lilly and Company Pruritus Ani Medicine Product Portfolios and Specifications
13.5.3 Eli Lilly and Company Pruritus Ani Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Eli Lilly and Company Main Business Overview
13.5.5 Eli Lilly and Company Latest Developments
13.6 GSK plc
13.6.1 GSK plc Company Information
13.6.2 GSK plc Pruritus Ani Medicine Product Portfolios and Specifications
13.6.3 GSK plc Pruritus Ani Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 GSK plc Main Business Overview
13.6.5 GSK plc Latest Developments
13.7 Merck & Co., Inc.
13.7.1 Merck & Co., Inc. Company Information
13.7.2 Merck & Co., Inc. Pruritus Ani Medicine Product Portfolios and Specifications
13.7.3 Merck & Co., Inc. Pruritus Ani Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Merck & Co., Inc. Main Business Overview
13.7.5 Merck & Co., Inc. Latest Developments
13.8 Pfizer, Inc.
13.8.1 Pfizer, Inc. Company Information
13.8.2 Pfizer, Inc. Pruritus Ani Medicine Product Portfolios and Specifications
13.8.3 Pfizer, Inc. Pruritus Ani Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Pfizer, Inc. Main Business Overview
13.8.5 Pfizer, Inc. Latest Developments
13.9 Teva Pharmaceutical Industries Ltd.
13.9.1 Teva Pharmaceutical Industries Ltd. Company Information
13.9.2 Teva Pharmaceutical Industries Ltd. Pruritus Ani Medicine Product Portfolios and Specifications
13.9.3 Teva Pharmaceutical Industries Ltd. Pruritus Ani Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Teva Pharmaceutical Industries Ltd. Main Business Overview
13.9.5 Teva Pharmaceutical Industries Ltd. Latest Developments
13.10 Viatris Inc. (Mylan N.V.)
13.10.1 Viatris Inc. (Mylan N.V.) Company Information
13.10.2 Viatris Inc. (Mylan N.V.) Pruritus Ani Medicine Product Portfolios and Specifications
13.10.3 Viatris Inc. (Mylan N.V.) Pruritus Ani Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Viatris Inc. (Mylan N.V.) Main Business Overview
13.10.5 Viatris Inc. (Mylan N.V.) Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Pruritus Ani Medicine Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Pruritus Ani Medicine Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of External Medication
Table 4. Major Players of Oral Medication
Table 5. Global Pruritus Ani Medicine Sales by Type (2021-2026) & (K Units)
Table 6. Global Pruritus Ani Medicine Sales Market Share by Type (2021-2026)
Table 7. Global Pruritus Ani Medicine Revenue by Type (2021-2026) & ($ million)
Table 8. Global Pruritus Ani Medicine Revenue Market Share by Type (2021-2026)
Table 9. Global Pruritus Ani Medicine Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global Pruritus Ani Medicine Sale by Application (2021-2026) & (K Units)
Table 11. Global Pruritus Ani Medicine Sale Market Share by Application (2021-2026)
Table 12. Global Pruritus Ani Medicine Revenue by Application (2021-2026) & ($ million)
Table 13. Global Pruritus Ani Medicine Revenue Market Share by Application (2021-2026)
Table 14. Global Pruritus Ani Medicine Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global Pruritus Ani Medicine Sales by Company (2021-2026) & (K Units)
Table 16. Global Pruritus Ani Medicine Sales Market Share by Company (2021-2026)
Table 17. Global Pruritus Ani Medicine Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Pruritus Ani Medicine Revenue Market Share by Company (2021-2026)
Table 19. Global Pruritus Ani Medicine Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers Pruritus Ani Medicine Producing Area Distribution and Sales Area
Table 21. Players Pruritus Ani Medicine Products Offered
Table 22. Pruritus Ani Medicine Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Pruritus Ani Medicine Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global Pruritus Ani Medicine Sales Market Share Geographic Region (2021-2026)
Table 27. Global Pruritus Ani Medicine Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Pruritus Ani Medicine Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Pruritus Ani Medicine Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global Pruritus Ani Medicine Sales Market Share by Country/Region (2021-2026)
Table 31. Global Pruritus Ani Medicine Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Pruritus Ani Medicine Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Pruritus Ani Medicine Sales by Country (2021-2026) & (K Units)
Table 34. Americas Pruritus Ani Medicine Sales Market Share by Country (2021-2026)
Table 35. Americas Pruritus Ani Medicine Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Pruritus Ani Medicine Sales by Type (2021-2026) & (K Units)
Table 37. Americas Pruritus Ani Medicine Sales by Application (2021-2026) & (K Units)
Table 38. APAC Pruritus Ani Medicine Sales by Region (2021-2026) & (K Units)
Table 39. APAC Pruritus Ani Medicine Sales Market Share by Region (2021-2026)
Table 40. APAC Pruritus Ani Medicine Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Pruritus Ani Medicine Sales by Type (2021-2026) & (K Units)
Table 42. APAC Pruritus Ani Medicine Sales by Application (2021-2026) & (K Units)
Table 43. Europe Pruritus Ani Medicine Sales by Country (2021-2026) & (K Units)
Table 44. Europe Pruritus Ani Medicine Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Pruritus Ani Medicine Sales by Type (2021-2026) & (K Units)
Table 46. Europe Pruritus Ani Medicine Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa Pruritus Ani Medicine Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa Pruritus Ani Medicine Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Pruritus Ani Medicine Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa Pruritus Ani Medicine Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Pruritus Ani Medicine
Table 52. Key Market Challenges & Risks of Pruritus Ani Medicine
Table 53. Key Industry Trends of Pruritus Ani Medicine
Table 54. Pruritus Ani Medicine Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Pruritus Ani Medicine Distributors List
Table 57. Pruritus Ani Medicine Customer List
Table 58. Global Pruritus Ani Medicine Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global Pruritus Ani Medicine Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Pruritus Ani Medicine Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas Pruritus Ani Medicine Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Pruritus Ani Medicine Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC Pruritus Ani Medicine Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Pruritus Ani Medicine Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe Pruritus Ani Medicine Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Pruritus Ani Medicine Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa Pruritus Ani Medicine Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Pruritus Ani Medicine Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global Pruritus Ani Medicine Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Pruritus Ani Medicine Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global Pruritus Ani Medicine Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. AbbVie, Inc. (Allergan plc) Basic Information, Pruritus Ani Medicine Manufacturing Base, Sales Area and Its Competitors
Table 73. AbbVie, Inc. (Allergan plc) Pruritus Ani Medicine Product Portfolios and Specifications
Table 74. AbbVie, Inc. (Allergan plc) Pruritus Ani Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. AbbVie, Inc. (Allergan plc) Main Business
Table 76. AbbVie, Inc. (Allergan plc) Latest Developments
Table 77. Albireo Pharma, Inc. Basic Information, Pruritus Ani Medicine Manufacturing Base, Sales Area and Its Competitors
Table 78. Albireo Pharma, Inc. Pruritus Ani Medicine Product Portfolios and Specifications
Table 79. Albireo Pharma, Inc. Pruritus Ani Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. Albireo Pharma, Inc. Main Business
Table 81. Albireo Pharma, Inc. Latest Developments
Table 82. Astellas Pharma Inc. Basic Information, Pruritus Ani Medicine Manufacturing Base, Sales Area and Its Competitors
Table 83. Astellas Pharma Inc. Pruritus Ani Medicine Product Portfolios and Specifications
Table 84. Astellas Pharma Inc. Pruritus Ani Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. Astellas Pharma Inc. Main Business
Table 86. Astellas Pharma Inc. Latest Developments
Table 87. Cipla Limited Basic Information, Pruritus Ani Medicine Manufacturing Base, Sales Area and Its Competitors
Table 88. Cipla Limited Pruritus Ani Medicine Product Portfolios and Specifications
Table 89. Cipla Limited Pruritus Ani Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. Cipla Limited Main Business
Table 91. Cipla Limited Latest Developments
Table 92. Eli Lilly and Company Basic Information, Pruritus Ani Medicine Manufacturing Base, Sales Area and Its Competitors
Table 93. Eli Lilly and Company Pruritus Ani Medicine Product Portfolios and Specifications
Table 94. Eli Lilly and Company Pruritus Ani Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. Eli Lilly and Company Main Business
Table 96. Eli Lilly and Company Latest Developments
Table 97. GSK plc Basic Information, Pruritus Ani Medicine Manufacturing Base, Sales Area and Its Competitors
Table 98. GSK plc Pruritus Ani Medicine Product Portfolios and Specifications
Table 99. GSK plc Pruritus Ani Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. GSK plc Main Business
Table 101. GSK plc Latest Developments
Table 102. Merck & Co., Inc. Basic Information, Pruritus Ani Medicine Manufacturing Base, Sales Area and Its Competitors
Table 103. Merck & Co., Inc. Pruritus Ani Medicine Product Portfolios and Specifications
Table 104. Merck & Co., Inc. Pruritus Ani Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. Merck & Co., Inc. Main Business
Table 106. Merck & Co., Inc. Latest Developments
Table 107. Pfizer, Inc. Basic Information, Pruritus Ani Medicine Manufacturing Base, Sales Area and Its Competitors
Table 108. Pfizer, Inc. Pruritus Ani Medicine Product Portfolios and Specifications
Table 109. Pfizer, Inc. Pruritus Ani Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 110. Pfizer, Inc. Main Business
Table 111. Pfizer, Inc. Latest Developments
Table 112. Teva Pharmaceutical Industries Ltd. Basic Information, Pruritus Ani Medicine Manufacturing Base, Sales Area and Its Competitors
Table 113. Teva Pharmaceutical Industries Ltd. Pruritus Ani Medicine Product Portfolios and Specifications
Table 114. Teva Pharmaceutical Industries Ltd. Pruritus Ani Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 115. Teva Pharmaceutical Industries Ltd. Main Business
Table 116. Teva Pharmaceutical Industries Ltd. Latest Developments
Table 117. Viatris Inc. (Mylan N.V.) Basic Information, Pruritus Ani Medicine Manufacturing Base, Sales Area and Its Competitors
Table 118. Viatris Inc. (Mylan N.V.) Pruritus Ani Medicine Product Portfolios and Specifications
Table 119. Viatris Inc. (Mylan N.V.) Pruritus Ani Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 120. Viatris Inc. (Mylan N.V.) Main Business
Table 121. Viatris Inc. (Mylan N.V.) Latest Developments
Table 1. Pruritus Ani Medicine Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Pruritus Ani Medicine Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of External Medication
Table 4. Major Players of Oral Medication
Table 5. Global Pruritus Ani Medicine Sales by Type (2021-2026) & (K Units)
Table 6. Global Pruritus Ani Medicine Sales Market Share by Type (2021-2026)
Table 7. Global Pruritus Ani Medicine Revenue by Type (2021-2026) & ($ million)
Table 8. Global Pruritus Ani Medicine Revenue Market Share by Type (2021-2026)
Table 9. Global Pruritus Ani Medicine Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global Pruritus Ani Medicine Sale by Application (2021-2026) & (K Units)
Table 11. Global Pruritus Ani Medicine Sale Market Share by Application (2021-2026)
Table 12. Global Pruritus Ani Medicine Revenue by Application (2021-2026) & ($ million)
Table 13. Global Pruritus Ani Medicine Revenue Market Share by Application (2021-2026)
Table 14. Global Pruritus Ani Medicine Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global Pruritus Ani Medicine Sales by Company (2021-2026) & (K Units)
Table 16. Global Pruritus Ani Medicine Sales Market Share by Company (2021-2026)
Table 17. Global Pruritus Ani Medicine Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Pruritus Ani Medicine Revenue Market Share by Company (2021-2026)
Table 19. Global Pruritus Ani Medicine Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers Pruritus Ani Medicine Producing Area Distribution and Sales Area
Table 21. Players Pruritus Ani Medicine Products Offered
Table 22. Pruritus Ani Medicine Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Pruritus Ani Medicine Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global Pruritus Ani Medicine Sales Market Share Geographic Region (2021-2026)
Table 27. Global Pruritus Ani Medicine Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Pruritus Ani Medicine Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Pruritus Ani Medicine Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global Pruritus Ani Medicine Sales Market Share by Country/Region (2021-2026)
Table 31. Global Pruritus Ani Medicine Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Pruritus Ani Medicine Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Pruritus Ani Medicine Sales by Country (2021-2026) & (K Units)
Table 34. Americas Pruritus Ani Medicine Sales Market Share by Country (2021-2026)
Table 35. Americas Pruritus Ani Medicine Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Pruritus Ani Medicine Sales by Type (2021-2026) & (K Units)
Table 37. Americas Pruritus Ani Medicine Sales by Application (2021-2026) & (K Units)
Table 38. APAC Pruritus Ani Medicine Sales by Region (2021-2026) & (K Units)
Table 39. APAC Pruritus Ani Medicine Sales Market Share by Region (2021-2026)
Table 40. APAC Pruritus Ani Medicine Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Pruritus Ani Medicine Sales by Type (2021-2026) & (K Units)
Table 42. APAC Pruritus Ani Medicine Sales by Application (2021-2026) & (K Units)
Table 43. Europe Pruritus Ani Medicine Sales by Country (2021-2026) & (K Units)
Table 44. Europe Pruritus Ani Medicine Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Pruritus Ani Medicine Sales by Type (2021-2026) & (K Units)
Table 46. Europe Pruritus Ani Medicine Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa Pruritus Ani Medicine Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa Pruritus Ani Medicine Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Pruritus Ani Medicine Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa Pruritus Ani Medicine Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Pruritus Ani Medicine
Table 52. Key Market Challenges & Risks of Pruritus Ani Medicine
Table 53. Key Industry Trends of Pruritus Ani Medicine
Table 54. Pruritus Ani Medicine Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Pruritus Ani Medicine Distributors List
Table 57. Pruritus Ani Medicine Customer List
Table 58. Global Pruritus Ani Medicine Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global Pruritus Ani Medicine Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Pruritus Ani Medicine Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas Pruritus Ani Medicine Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Pruritus Ani Medicine Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC Pruritus Ani Medicine Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Pruritus Ani Medicine Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe Pruritus Ani Medicine Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Pruritus Ani Medicine Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa Pruritus Ani Medicine Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Pruritus Ani Medicine Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global Pruritus Ani Medicine Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Pruritus Ani Medicine Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global Pruritus Ani Medicine Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. AbbVie, Inc. (Allergan plc) Basic Information, Pruritus Ani Medicine Manufacturing Base, Sales Area and Its Competitors
Table 73. AbbVie, Inc. (Allergan plc) Pruritus Ani Medicine Product Portfolios and Specifications
Table 74. AbbVie, Inc. (Allergan plc) Pruritus Ani Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. AbbVie, Inc. (Allergan plc) Main Business
Table 76. AbbVie, Inc. (Allergan plc) Latest Developments
Table 77. Albireo Pharma, Inc. Basic Information, Pruritus Ani Medicine Manufacturing Base, Sales Area and Its Competitors
Table 78. Albireo Pharma, Inc. Pruritus Ani Medicine Product Portfolios and Specifications
Table 79. Albireo Pharma, Inc. Pruritus Ani Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. Albireo Pharma, Inc. Main Business
Table 81. Albireo Pharma, Inc. Latest Developments
Table 82. Astellas Pharma Inc. Basic Information, Pruritus Ani Medicine Manufacturing Base, Sales Area and Its Competitors
Table 83. Astellas Pharma Inc. Pruritus Ani Medicine Product Portfolios and Specifications
Table 84. Astellas Pharma Inc. Pruritus Ani Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. Astellas Pharma Inc. Main Business
Table 86. Astellas Pharma Inc. Latest Developments
Table 87. Cipla Limited Basic Information, Pruritus Ani Medicine Manufacturing Base, Sales Area and Its Competitors
Table 88. Cipla Limited Pruritus Ani Medicine Product Portfolios and Specifications
Table 89. Cipla Limited Pruritus Ani Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. Cipla Limited Main Business
Table 91. Cipla Limited Latest Developments
Table 92. Eli Lilly and Company Basic Information, Pruritus Ani Medicine Manufacturing Base, Sales Area and Its Competitors
Table 93. Eli Lilly and Company Pruritus Ani Medicine Product Portfolios and Specifications
Table 94. Eli Lilly and Company Pruritus Ani Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. Eli Lilly and Company Main Business
Table 96. Eli Lilly and Company Latest Developments
Table 97. GSK plc Basic Information, Pruritus Ani Medicine Manufacturing Base, Sales Area and Its Competitors
Table 98. GSK plc Pruritus Ani Medicine Product Portfolios and Specifications
Table 99. GSK plc Pruritus Ani Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. GSK plc Main Business
Table 101. GSK plc Latest Developments
Table 102. Merck & Co., Inc. Basic Information, Pruritus Ani Medicine Manufacturing Base, Sales Area and Its Competitors
Table 103. Merck & Co., Inc. Pruritus Ani Medicine Product Portfolios and Specifications
Table 104. Merck & Co., Inc. Pruritus Ani Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. Merck & Co., Inc. Main Business
Table 106. Merck & Co., Inc. Latest Developments
Table 107. Pfizer, Inc. Basic Information, Pruritus Ani Medicine Manufacturing Base, Sales Area and Its Competitors
Table 108. Pfizer, Inc. Pruritus Ani Medicine Product Portfolios and Specifications
Table 109. Pfizer, Inc. Pruritus Ani Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 110. Pfizer, Inc. Main Business
Table 111. Pfizer, Inc. Latest Developments
Table 112. Teva Pharmaceutical Industries Ltd. Basic Information, Pruritus Ani Medicine Manufacturing Base, Sales Area and Its Competitors
Table 113. Teva Pharmaceutical Industries Ltd. Pruritus Ani Medicine Product Portfolios and Specifications
Table 114. Teva Pharmaceutical Industries Ltd. Pruritus Ani Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 115. Teva Pharmaceutical Industries Ltd. Main Business
Table 116. Teva Pharmaceutical Industries Ltd. Latest Developments
Table 117. Viatris Inc. (Mylan N.V.) Basic Information, Pruritus Ani Medicine Manufacturing Base, Sales Area and Its Competitors
Table 118. Viatris Inc. (Mylan N.V.) Pruritus Ani Medicine Product Portfolios and Specifications
Table 119. Viatris Inc. (Mylan N.V.) Pruritus Ani Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 120. Viatris Inc. (Mylan N.V.) Main Business
Table 121. Viatris Inc. (Mylan N.V.) Latest Developments
LIST OF FIGURES
Figure 1. Picture of Pruritus Ani Medicine
Figure 2. Pruritus Ani Medicine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Pruritus Ani Medicine Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Pruritus Ani Medicine Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Pruritus Ani Medicine Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Pruritus Ani Medicine Sales Market Share by Country/Region (2025)
Figure 10. Pruritus Ani Medicine Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of External Medication
Figure 12. Product Picture of Oral Medication
Figure 13. Global Pruritus Ani Medicine Sales Market Share by Type in 2026
Figure 14. Global Pruritus Ani Medicine Revenue Market Share by Type (2021-2026)
Figure 15. Pruritus Ani Medicine Consumed in Hospital Pharmacies
Figure 16. Global Pruritus Ani Medicine Market: Hospital Pharmacies (2021-2026) & (K Units)
Figure 17. Pruritus Ani Medicine Consumed in Retail Pharmacies
Figure 18. Global Pruritus Ani Medicine Market: Retail Pharmacies (2021-2026) & (K Units)
Figure 19. Pruritus Ani Medicine Consumed in Online Pharmacies
Figure 20. Global Pruritus Ani Medicine Market: Online Pharmacies (2021-2026) & (K Units)
Figure 21. Global Pruritus Ani Medicine Sale Market Share by Application (2025)
Figure 22. Global Pruritus Ani Medicine Revenue Market Share by Application in 2026
Figure 23. Pruritus Ani Medicine Sales by Company in 2026 (K Units)
Figure 24. Global Pruritus Ani Medicine Sales Market Share by Company in 2026
Figure 25. Pruritus Ani Medicine Revenue by Company in 2026 ($ millions)
Figure 26. Global Pruritus Ani Medicine Revenue Market Share by Company in 2026
Figure 27. Global Pruritus Ani Medicine Sales Market Share by Geographic Region (2021-2026)
Figure 28. Global Pruritus Ani Medicine Revenue Market Share by Geographic Region in 2026
Figure 29. Americas Pruritus Ani Medicine Sales 2021-2026 (K Units)
Figure 30. Americas Pruritus Ani Medicine Revenue 2021-2026 ($ millions)
Figure 31. APAC Pruritus Ani Medicine Sales 2021-2026 (K Units)
Figure 32. APAC Pruritus Ani Medicine Revenue 2021-2026 ($ millions)
Figure 33. Europe Pruritus Ani Medicine Sales 2021-2026 (K Units)
Figure 34. Europe Pruritus Ani Medicine Revenue 2021-2026 ($ millions)
Figure 35. Middle East & Africa Pruritus Ani Medicine Sales 2021-2026 (K Units)
Figure 36. Middle East & Africa Pruritus Ani Medicine Revenue 2021-2026 ($ millions)
Figure 37. Americas Pruritus Ani Medicine Sales Market Share by Country in 2026
Figure 38. Americas Pruritus Ani Medicine Revenue Market Share by Country (2021-2026)
Figure 39. Americas Pruritus Ani Medicine Sales Market Share by Type (2021-2026)
Figure 40. Americas Pruritus Ani Medicine Sales Market Share by Application (2021-2026)
Figure 41. United States Pruritus Ani Medicine Revenue Growth 2021-2026 ($ millions)
Figure 42. Canada Pruritus Ani Medicine Revenue Growth 2021-2026 ($ millions)
Figure 43. Mexico Pruritus Ani Medicine Revenue Growth 2021-2026 ($ millions)
Figure 44. Brazil Pruritus Ani Medicine Revenue Growth 2021-2026 ($ millions)
Figure 45. APAC Pruritus Ani Medicine Sales Market Share by Region in 2026
Figure 46. APAC Pruritus Ani Medicine Revenue Market Share by Region (2021-2026)
Figure 47. APAC Pruritus Ani Medicine Sales Market Share by Type (2021-2026)
Figure 48. APAC Pruritus Ani Medicine Sales Market Share by Application (2021-2026)
Figure 49. China Pruritus Ani Medicine Revenue Growth 2021-2026 ($ millions)
Figure 50. Japan Pruritus Ani Medicine Revenue Growth 2021-2026 ($ millions)
Figure 51. South Korea Pruritus Ani Medicine Revenue Growth 2021-2026 ($ millions)
Figure 52. Southeast Asia Pruritus Ani Medicine Revenue Growth 2021-2026 ($ millions)
Figure 53. India Pruritus Ani Medicine Revenue Growth 2021-2026 ($ millions)
Figure 54. Australia Pruritus Ani Medicine Revenue Growth 2021-2026 ($ millions)
Figure 55. China Taiwan Pruritus Ani Medicine Revenue Growth 2021-2026 ($ millions)
Figure 56. Europe Pruritus Ani Medicine Sales Market Share by Country in 2026
Figure 57. Europe Pruritus Ani Medicine Revenue Market Share by Country (2021-2026)
Figure 58. Europe Pruritus Ani Medicine Sales Market Share by Type (2021-2026)
Figure 59. Europe Pruritus Ani Medicine Sales Market Share by Application (2021-2026)
Figure 60. Germany Pruritus Ani Medicine Revenue Growth 2021-2026 ($ millions)
Figure 61. France Pruritus Ani Medicine Revenue Growth 2021-2026 ($ millions)
Figure 62. UK Pruritus Ani Medicine Revenue Growth 2021-2026 ($ millions)
Figure 63. Italy Pruritus Ani Medicine Revenue Growth 2021-2026 ($ millions)
Figure 64. Russia Pruritus Ani Medicine Revenue Growth 2021-2026 ($ millions)
Figure 65. Middle East & Africa Pruritus Ani Medicine Sales Market Share by Country (2021-2026)
Figure 66. Middle East & Africa Pruritus Ani Medicine Sales Market Share by Type (2021-2026)
Figure 67. Middle East & Africa Pruritus Ani Medicine Sales Market Share by Application (2021-2026)
Figure 68. Egypt Pruritus Ani Medicine Revenue Growth 2021-2026 ($ millions)
Figure 69. South Africa Pruritus Ani Medicine Revenue Growth 2021-2026 ($ millions)
Figure 70. Israel Pruritus Ani Medicine Revenue Growth 2021-2026 ($ millions)
Figure 71. Turkey Pruritus Ani Medicine Revenue Growth 2021-2026 ($ millions)
Figure 72. GCC Countries Pruritus Ani Medicine Revenue Growth 2021-2026 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Pruritus Ani Medicine in 2026
Figure 74. Manufacturing Process Analysis of Pruritus Ani Medicine
Figure 75. Industry Chain Structure of Pruritus Ani Medicine
Figure 76. Channels of Distribution
Figure 77. Global Pruritus Ani Medicine Sales Market Forecast by Region (2027-2032)
Figure 78. Global Pruritus Ani Medicine Revenue Market Share Forecast by Region (2027-2032)
Figure 79. Global Pruritus Ani Medicine Sales Market Share Forecast by Type (2027-2032)
Figure 80. Global Pruritus Ani Medicine Revenue Market Share Forecast by Type (2027-2032)
Figure 81. Global Pruritus Ani Medicine Sales Market Share Forecast by Application (2027-2032)
Figure 82. Global Pruritus Ani Medicine Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Pruritus Ani Medicine
Figure 2. Pruritus Ani Medicine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Pruritus Ani Medicine Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Pruritus Ani Medicine Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Pruritus Ani Medicine Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Pruritus Ani Medicine Sales Market Share by Country/Region (2025)
Figure 10. Pruritus Ani Medicine Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of External Medication
Figure 12. Product Picture of Oral Medication
Figure 13. Global Pruritus Ani Medicine Sales Market Share by Type in 2026
Figure 14. Global Pruritus Ani Medicine Revenue Market Share by Type (2021-2026)
Figure 15. Pruritus Ani Medicine Consumed in Hospital Pharmacies
Figure 16. Global Pruritus Ani Medicine Market: Hospital Pharmacies (2021-2026) & (K Units)
Figure 17. Pruritus Ani Medicine Consumed in Retail Pharmacies
Figure 18. Global Pruritus Ani Medicine Market: Retail Pharmacies (2021-2026) & (K Units)
Figure 19. Pruritus Ani Medicine Consumed in Online Pharmacies
Figure 20. Global Pruritus Ani Medicine Market: Online Pharmacies (2021-2026) & (K Units)
Figure 21. Global Pruritus Ani Medicine Sale Market Share by Application (2025)
Figure 22. Global Pruritus Ani Medicine Revenue Market Share by Application in 2026
Figure 23. Pruritus Ani Medicine Sales by Company in 2026 (K Units)
Figure 24. Global Pruritus Ani Medicine Sales Market Share by Company in 2026
Figure 25. Pruritus Ani Medicine Revenue by Company in 2026 ($ millions)
Figure 26. Global Pruritus Ani Medicine Revenue Market Share by Company in 2026
Figure 27. Global Pruritus Ani Medicine Sales Market Share by Geographic Region (2021-2026)
Figure 28. Global Pruritus Ani Medicine Revenue Market Share by Geographic Region in 2026
Figure 29. Americas Pruritus Ani Medicine Sales 2021-2026 (K Units)
Figure 30. Americas Pruritus Ani Medicine Revenue 2021-2026 ($ millions)
Figure 31. APAC Pruritus Ani Medicine Sales 2021-2026 (K Units)
Figure 32. APAC Pruritus Ani Medicine Revenue 2021-2026 ($ millions)
Figure 33. Europe Pruritus Ani Medicine Sales 2021-2026 (K Units)
Figure 34. Europe Pruritus Ani Medicine Revenue 2021-2026 ($ millions)
Figure 35. Middle East & Africa Pruritus Ani Medicine Sales 2021-2026 (K Units)
Figure 36. Middle East & Africa Pruritus Ani Medicine Revenue 2021-2026 ($ millions)
Figure 37. Americas Pruritus Ani Medicine Sales Market Share by Country in 2026
Figure 38. Americas Pruritus Ani Medicine Revenue Market Share by Country (2021-2026)
Figure 39. Americas Pruritus Ani Medicine Sales Market Share by Type (2021-2026)
Figure 40. Americas Pruritus Ani Medicine Sales Market Share by Application (2021-2026)
Figure 41. United States Pruritus Ani Medicine Revenue Growth 2021-2026 ($ millions)
Figure 42. Canada Pruritus Ani Medicine Revenue Growth 2021-2026 ($ millions)
Figure 43. Mexico Pruritus Ani Medicine Revenue Growth 2021-2026 ($ millions)
Figure 44. Brazil Pruritus Ani Medicine Revenue Growth 2021-2026 ($ millions)
Figure 45. APAC Pruritus Ani Medicine Sales Market Share by Region in 2026
Figure 46. APAC Pruritus Ani Medicine Revenue Market Share by Region (2021-2026)
Figure 47. APAC Pruritus Ani Medicine Sales Market Share by Type (2021-2026)
Figure 48. APAC Pruritus Ani Medicine Sales Market Share by Application (2021-2026)
Figure 49. China Pruritus Ani Medicine Revenue Growth 2021-2026 ($ millions)
Figure 50. Japan Pruritus Ani Medicine Revenue Growth 2021-2026 ($ millions)
Figure 51. South Korea Pruritus Ani Medicine Revenue Growth 2021-2026 ($ millions)
Figure 52. Southeast Asia Pruritus Ani Medicine Revenue Growth 2021-2026 ($ millions)
Figure 53. India Pruritus Ani Medicine Revenue Growth 2021-2026 ($ millions)
Figure 54. Australia Pruritus Ani Medicine Revenue Growth 2021-2026 ($ millions)
Figure 55. China Taiwan Pruritus Ani Medicine Revenue Growth 2021-2026 ($ millions)
Figure 56. Europe Pruritus Ani Medicine Sales Market Share by Country in 2026
Figure 57. Europe Pruritus Ani Medicine Revenue Market Share by Country (2021-2026)
Figure 58. Europe Pruritus Ani Medicine Sales Market Share by Type (2021-2026)
Figure 59. Europe Pruritus Ani Medicine Sales Market Share by Application (2021-2026)
Figure 60. Germany Pruritus Ani Medicine Revenue Growth 2021-2026 ($ millions)
Figure 61. France Pruritus Ani Medicine Revenue Growth 2021-2026 ($ millions)
Figure 62. UK Pruritus Ani Medicine Revenue Growth 2021-2026 ($ millions)
Figure 63. Italy Pruritus Ani Medicine Revenue Growth 2021-2026 ($ millions)
Figure 64. Russia Pruritus Ani Medicine Revenue Growth 2021-2026 ($ millions)
Figure 65. Middle East & Africa Pruritus Ani Medicine Sales Market Share by Country (2021-2026)
Figure 66. Middle East & Africa Pruritus Ani Medicine Sales Market Share by Type (2021-2026)
Figure 67. Middle East & Africa Pruritus Ani Medicine Sales Market Share by Application (2021-2026)
Figure 68. Egypt Pruritus Ani Medicine Revenue Growth 2021-2026 ($ millions)
Figure 69. South Africa Pruritus Ani Medicine Revenue Growth 2021-2026 ($ millions)
Figure 70. Israel Pruritus Ani Medicine Revenue Growth 2021-2026 ($ millions)
Figure 71. Turkey Pruritus Ani Medicine Revenue Growth 2021-2026 ($ millions)
Figure 72. GCC Countries Pruritus Ani Medicine Revenue Growth 2021-2026 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Pruritus Ani Medicine in 2026
Figure 74. Manufacturing Process Analysis of Pruritus Ani Medicine
Figure 75. Industry Chain Structure of Pruritus Ani Medicine
Figure 76. Channels of Distribution
Figure 77. Global Pruritus Ani Medicine Sales Market Forecast by Region (2027-2032)
Figure 78. Global Pruritus Ani Medicine Revenue Market Share Forecast by Region (2027-2032)
Figure 79. Global Pruritus Ani Medicine Sales Market Share Forecast by Type (2027-2032)
Figure 80. Global Pruritus Ani Medicine Revenue Market Share Forecast by Type (2027-2032)
Figure 81. Global Pruritus Ani Medicine Sales Market Share Forecast by Application (2027-2032)
Figure 82. Global Pruritus Ani Medicine Revenue Market Share Forecast by Application (2027-2032)
